🍪 CompoundTalk uses cookies to improve your experience, analyze traffic, and personalize content. By continuing to use this site, you agree to our Cookie Policy.
Evidence-based GLP-1 & peptide discussion since 2023
ForumsCompounding & FormulationHas anyone dealt with compounding pharmacy accreditation: pcab vs achc vs state-only? Page 3

Has anyone dealt with compounding pharmacy accreditation: pcab vs achc vs state-only?

mel_PDX Wed, Apr 16, 2025 at 3:28 AM 39 replies 1,918 viewsPage 3 of 8
lisa_labSD
Member
278
1,234
Oct 2024
San Diego, CA
Apr 16, 2025 at 7:43 AM#11

+1 to JennaRN. Especially the point about "Re: Has anyone dealt with — the effect s..." — I have seen the same in my own experience with Has anyone dealt with.

Last edited: Apr 16, 2025 at 10:43 AM
50 20stefan_berlin, Dr.EM_Chicago, pete_RVA and 47 others
Reply Quote Save Share Report
NurseLeah_Nash
Member
278
1,234
Sep 2024
Nashville, TN
Apr 16, 2025 at 8:00 AM#12

Want to share my personal experience related to Has anyone dealt with since I think it might help others in a similar situation.

I started my GLP-1 journey in October 2024 at 276 lbs with prediabetes and hypertension. My endocrinologist prescribed semaglutide 0.25mg to start.

Now, 8 months later: I am down 51 lbs, my labs have normalized, and I am off 2 of my 3 medications. The Has anyone dealt aspect specifically was something that made a big difference in my journey.

This community helped me every step of the way.

1 20BiostatsBrad
Reply Quote Save Share Report
chris_chi24
Member
389
1,678
Sep 2024
Chicago, IL
Apr 16, 2025 at 8:17 AM#13

TinaHashiRN — that is really helpful context on Has anyone dealt with. Follow-up question: did you experience any side effects during this phase?

I am in a similar situation (about to start) and trying to set realistic expectations.

47 0MaxMetOK, MounjBrad, nick_newbie and 44 others
Reply Quote Save Share Report

PeptideMeter — Independent Peptide Analytics

Community-driven peptide testing and vendor rating platform. Transparent results. Unbiased analysis. Trusted by thousands.

View Results
TrialTracker_MD
Senior Member
2,345
15,678
Jan 2024
Maryland
Apr 16, 2025 at 8:34 AM#14

To answer NurseLeah_Nash's question specifically:

From a clinical standpoint, Has anyone dealt with is something I discuss with patients regularly.

The short answer: discuss this specific situation with your prescribing provider.

The longer answer involves weighing the risk-benefit ratio for your individual situation, which I am happy to elaborate on if helpful.

Last edited: Apr 16, 2025 at 1:34 PM
13 4Dr.PulmRoch, maya_sedona, stefan_berlin and 10 others
Reply Quote Save Share Report
MounjBrad
Member
278
890
Oct 2024
Kentucky
Apr 16, 2025 at 8:51 AM#15

Saving this for reference. Quality thread.

31 7marco_milano, pam_columbus, nick_SD_fit and 28 others
Reply Quote Save Share Report

Similar Threads

503A vs 503B compounding — regulatory framework explained4 replies
Compounded semaglutide stability: accelerated degradation study results6 replies
Lyophilized vs liquid peptides — stability and bioavailability comparison18 replies
Bacteriostatic water sourcing and sterility considerations8 replies
State-by-state compounding pharmacy regulations — 2026 map8 replies
ForumsNewTrendingMembersAccount

Log In

Forgot password?
No account? Register